+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Diabetic Pens Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • May 2021
  • Region: Global
  • TechNavio
  • ID: 4994812
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the diabetic pens market and it is poised to grow by $ 3.65 billion during 2021-2025, progressing at a CAGR of over 8% during the forecast period. The report on the diabetic pens market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of diabetes and the availability of Diabetes Self-Management Education Programs.

The diabetic pens market analysis includes the product segment and geographic landscape.

The diabetic pens market is segmented as below:

By Product
  • Reusable diabetic pens
  • Disposable diabetic pens

By Geographical Landscape
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing demand for diabetic injection pens as one of the prime reasons driving the diabetic pens market growth during the next few years.

The report on diabetic pens market covers the following areas:
  • Diabetic pens market sizing
  • Diabetic pens market forecast
  • Diabetic pens market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diabetic pens market vendors that include AstraZeneca Plc, Becton, Dickinson and Co., Biocon Ltd., Companion Medical Inc., Digital Medics Pvt. Ltd., Eli Lilly and Co., Emperra GmbH E-Health Technologies, Jiangsu Delfu medical device Co. Ltd., Novo Nordisk AS, and Sanofi SA. Also, the diabetic pens market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Reusable diabetic pens - Market size and forecast 2020-2025
  • Disposable diabetic pens - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AstraZeneca Plc
  • Biocon Ltd.
  • Companion Medical Inc.
  • Digital Medics Pvt. Ltd.
  • Eli Lilly and Co.
  • Emperra GmbH E-Health Technologies
  • Jiangsu Delfu medical device Co. Ltd.
  • Novo Nordisk AS
  • Sanofi SA

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Reusable diabetic pens - Market size and forecast 2020-2025 ($ million)
  • Reusable diabetic pens - Year-over-year growth 2020-2025 (%)
  • Disposable diabetic pens - Market size and forecast 2020-2025 ($ million)
  • Disposable diabetic pens - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product and service
  • AstraZeneca Plc - Key offerings
  • AstraZeneca Plc - Key customers
  • AstraZeneca Plc - Segment focus
  • Becton, Dickinson and Co. - Overview
  • Becton, Dickinson and Co. - Business segments
  • Becton, Dickinson and Co. - Key offerings
  • Becton, Dickinson and Co. - Key customers
  • Becton, Dickinson and Co. - Segment focus
  • Biocon Ltd. - Overview
  • Biocon Ltd. - Business segments
  • Biocon Ltd. - Key offerings
  • Biocon Ltd. - Key customers
  • Biocon Ltd. - Segment focus
  • Companion Medical Inc. - Overview
  • Companion Medical Inc. - Product and service
  • Companion Medical Inc. - Key offerings
  • Companion Medical Inc. - Key customers
  • Companion Medical Inc. - Segment focus
  • Digital Medics Pvt. Ltd. - Overview
  • Digital Medics Pvt. Ltd. - Product and service
  • Digital Medics Pvt. Ltd. - Key offerings
  • Digital Medics Pvt. Ltd. - Key customers
  • Digital Medics Pvt. Ltd. - Segment focus
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Business segments
  • Eli Lilly and Co. - Key offerings
  • Eli Lilly and Co. - Key customers
  • Eli Lilly and Co. - Segment focus
  • Emperra GmbH E-Health Technologies - Overview
  • Emperra GmbH E-Health Technologies - Product and service
  • Emperra GmbH E-Health Technologies - Key offerings
  • Emperra GmbH E-Health Technologies - Key customers
  • Emperra GmbH E-Health Technologies - Segment focus
  • Jiangsu Delfu medical device Co. Ltd. - Overview
  • Jiangsu Delfu medical device Co. Ltd. - Product and service
  • Jiangsu Delfu medical device Co. Ltd. - Key offerings
  • Jiangsu Delfu medical device Co. Ltd. - Key customers
  • Jiangsu Delfu medical device Co. Ltd. - Segment focus
  • Novo Nordisk AS - Overview
  • Novo Nordisk AS - Business segments
  • Novo Nordisk AS - Key offerings
  • Novo Nordisk AS - Key customers
  • Novo Nordisk AS - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global diabetic pens market: AstraZeneca Plc, Becton, Dickinson and Co., Biocon Ltd., Companion Medical Inc., Digital Medics Pvt. Ltd., Eli Lilly and Co., Emperra GmbH E-Health Technologies, Jiangsu Delfu medical device Co. Ltd., Novo Nordisk AS, and Sanofi SA.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the increasing demand for diabetic injection pens.`

According to the report, one of the major drivers for this market is the increasing prevalence of diabetes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AstraZeneca Plc
  • Becton
  • Dickinson and Co.
  • Biocon Ltd.
  • Companion Medical Inc.
  • Digital Medics Pvt. Ltd.
  • Eli Lilly and Co.
  • Emperra GmbH E-Health Technologies
  • Jiangsu Delfu medical device Co. Ltd.
  • Novo Nordisk AS
  • Sanofi SA